Sophia N Karagiannnis

78PUBLICATIONS
249CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersAllergyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Sep 12, 2026
Physical activity in advanced urological cancers undergoing immune checkpoint inhibitor treatment: a qualitative study exploring patient perspectives and experiences.

|Aug 26, 2026
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.

|Aug 08, 2026
Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma Patients.

|Aug 07, 2026
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.

|Jul 23, 2026
Basophils in Immunity: Activation Pathways, Roles in Allergy and AllergoOncology and Application of the Basophil Activation Test.

|Jun 24, 2026
Melittin in AllergoOncology: From Honey Bee Venom to Anti-Cancer Therapeutic Innovation-An EAACI Position Paper.

Pageof 13

Frequent Collaborators

27 joint publications

Heather J Bax

14 joint publications

Erika Jensen-Jarolim

12 joint publications

Rodolfo Bianchini

12 joint publications

Silvia Crescioli